Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ZEVRA THERAPEUTICS, INC. | SVP, Corporate Controller | Restricted Stock Unit | 35K | $174K | $4.96 | Jan 31, 2024 | Direct |
ZEVRA THERAPEUTICS, INC. | SVP, Corporate Controller | Common Stock | 4.45K | $22.1K | $4.96 | Mar 10, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ZVRA | ZEVRA THERAPEUTICS, INC. | Jan 31, 2024 | 1 | $0 | 4 | Feb 2, 2024 | SVP, Corporate Controller |
ZVRA | ZEVRA THERAPEUTICS, INC. | Mar 10, 2023 | 2 | $4.97K | 4 | Mar 13, 2023 | SVP, Corporate Controller |
ZVRA | KEMPHARM, INC | Jan 9, 2023 | 1 | $0 | 4 | Jan 11, 2023 | SVP, Corporate Controller |
ZVRA | KEMPHARM, INC | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | VP, Corporate Controller |
ZVRA | KEMPHARM, INC | Aug 20, 2021 | 1 | $0 | 4 | Aug 24, 2021 | VP, Corporate Controller |